📉 The Financial Deep Dive
Aster DM Healthcare Limited's proposed merger with Quality Care India Limited (QCIL) is set to create a formidable force in the Indian healthcare landscape, aiming to rank among the top three hospital chains nationally. The proforma combined entity, to be christened Aster DM Quality Care Limited, will command a significant presence with over 10,625 beds across 28 cities, with plans for further expansion to approximately 14,710 beds.
The Numbers:
For the third quarter of Fiscal Year 2026 (Q3FY26), the proforma combined entity demonstrated impressive financial momentum. Revenue surged by a notable 15% year-on-year (YoY) to INR 2,366 crore. Total patient volumes saw a healthy 9% YoY increase to 1.97 million. Operating EBITDA displayed robust growth, jumping 22% YoY to INR 503 crore. This was accompanied by an improvement in EBITDA margins, which expanded to 21% from 20% in Q3FY25, indicating effective operational leverage.
On a nine-month basis for FY26 (9MFY26), the combined entity's revenue reached INR 6,913 crore, a 13% YoY rise. Operating EBITDA grew by 20% YoY to INR 1,496 crore, maintaining healthy EBITDA margins at 21.6%.
Aster DM Healthcare's standalone performance for Q3FY26 also showed positive trends, with revenue up 13% YoY to INR 1,186 crore and EBITDA increasing 11% YoY to INR 224 crore.
The Quality:
The merger is structured to be cash neutral for shareholders and is anticipated to be Earnings Per Share (EPS) accretive from the first full year of operation. The strategic rationale emphasizes scale, enhanced financial and operational metrics, and the realization of significant revenue and cost synergies, estimated to provide a near-term EBITDA upside potential of 10-15%. The backing of global investor Blackstone adds financial credibility and strategic support.
Financially, the combined entity reported INR 953 crore in net debt and a Return on Capital Employed (RoCE) of 20.7% for Q3FY26. Aster DM Healthcare's standalone balance sheet indicates an increase in Property, Plant, and Equipment (PPE) and significant growth in Lease Liabilities under INDAS116, a common accounting treatment for leases impacting asset and liability recognition.
Risks & Outlook:
The primary risks revolve around the successful integration of the two entities and the realization of projected synergies. The merger process is ongoing, with filings made to the National Company Law Tribunal (NCLT) and shareholder meetings scheduled. The expected completion in Q1FY27 means investors will monitor execution closely. Disciplined brownfield and greenfield expansions are planned, which will require careful capital allocation. The market will be watching for how effectively the enlarged entity leverages its scale to drive further growth and profitability in an increasingly competitive healthcare sector.